Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter G Bardy

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Stem Cells (Dayton, Ohio)|June 4, 2009
Human gastrointestinal neoplasia-associated myofibroblasts can develop from bone marrow-derived cells following allogeneic stem cell transplantationDaniel L Worthley, Andrew Ruszkiewicz, Ruth Davies, et al.
Transplantation and Cellular Therapy|November 29, 2023
Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with Acute Myeloid Leukemia and Myelodysplastic Syndromes Demonstrates Long Term Survival, Results from Australia and New Zealand Transplant and Cellular TherapiesEdward Abadir, Jad Othman, John Kwan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 16, 2009
Donor mannose-binding lectin deficiency increases the likelihood of clinically significant infection after liver transplantationDaniel L Worthley, Douglas F Johnson, Damon P Eisen, et al.
The Journal of Biological Chemistry|January 22, 2013
Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cellsSusan L Heatley, Gabriella Pietra, Jie Lin, et al.
The Lancet. Infectious Diseases|May 4, 2013
Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trialC Orla Morrissey, Sharon C-A Chen, Tania C Sorrell, et al.
Haematologica|October 7, 2017
Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndromeDeepak Singhal, Monika M Kutyna, Rakchha Chhetri, et al.
Pathology|August 28, 2022
Novel modes of MPL activation in triple-negative myeloproliferative neoplasmsSaumya E Samaraweera, Tatjana Geukens, Debora A Casolari, et al.
Blood|December 8, 2011
Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculatureJan Kazenwadel, Genevieve A Secker, Yajuan J Liu, et al.
The New England Journal of Medicine|May 10, 2013
A no-prophylaxis platelet-transfusion strategy for hematologic cancersSimon J Stanworth, Lise J Estcourt, Gillian Powter, et al.
Leukemia|May 16, 2019
The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distributionDeepak Singhal, Li Yan A Wee, Monika M Kutyna, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Stem Cells (Dayton, Ohio)|June 4, 2009
Human gastrointestinal neoplasia-associated myofibroblasts can develop from bone marrow-derived cells following allogeneic stem cell transplantationDaniel L Worthley, Andrew Ruszkiewicz, Ruth Davies, et al.
Transplantation and Cellular Therapy|November 29, 2023
Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with Acute Myeloid Leukemia and Myelodysplastic Syndromes Demonstrates Long Term Survival, Results from Australia and New Zealand Transplant and Cellular TherapiesEdward Abadir, Jad Othman, John Kwan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 16, 2009
Donor mannose-binding lectin deficiency increases the likelihood of clinically significant infection after liver transplantationDaniel L Worthley, Douglas F Johnson, Damon P Eisen, et al.
The Journal of Biological Chemistry|January 22, 2013
Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cellsSusan L Heatley, Gabriella Pietra, Jie Lin, et al.
The Lancet. Infectious Diseases|May 4, 2013
Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trialC Orla Morrissey, Sharon C-A Chen, Tania C Sorrell, et al.
Haematologica|October 7, 2017
Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndromeDeepak Singhal, Monika M Kutyna, Rakchha Chhetri, et al.
Pathology|August 28, 2022
Novel modes of MPL activation in triple-negative myeloproliferative neoplasmsSaumya E Samaraweera, Tatjana Geukens, Debora A Casolari, et al.
Blood|December 8, 2011
Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculatureJan Kazenwadel, Genevieve A Secker, Yajuan J Liu, et al.
The New England Journal of Medicine|May 10, 2013
A no-prophylaxis platelet-transfusion strategy for hematologic cancersSimon J Stanworth, Lise J Estcourt, Gillian Powter, et al.
Leukemia|May 16, 2019
The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distributionDeepak Singhal, Li Yan A Wee, Monika M Kutyna, et al.
Pageof 3